Clinical trial NCT04766411: Recovery Kinetics After Different Sprint Training Protocols (STRecovery)
Official title: Recovery Kinetics After Different Sprint Training Protocols
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Sprint Training
Keywords: sprint training
muscle damage
muscle performance
neuromuscular fatigue
recovery
Lead sponsor: University of Thessaly
Sponsor class: OTHER
First posted: 2021-02-23
Enrollment: 10
Sex: MALE
Minimum age (years): 18
Maximum age (years): 30
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: SCREENING

Brief summary: Speed is one of the most important physical capacities for many sports, especially those that include speed and power as a major element, and plays a major role on performance. Running speed improvement is one of the most basic components of a sprint and power athlete's training program. One of the most commonly used strategies to improve the initial acceleration phase, is resisted sprint training. Sprinting is performed through the stretch-shortening cycle and highly includes the component of eccentric muscle contraction, which can lead to exercise induced muscle damage (EIMD). This phenomenon includes symptoms such as plasma CK elevation, delayed onset of muscle soreness, reduction in force production and a reduction in agility and speed. However, despite the fact that sprint training can cause EIMD symptoms and a performance reduction the following days, research evidence on the recovery kinetics after sprint training are scarce. However, such information is critical for coaches and athletes, in order to effectively design a training program and incorporate the training components in the training microcycle, to avoid injuries and maximize performance. The aim of the present study is to examine the recovery kinetics of EIMD indices, muscle performance and neuromuscular fatigue, after different sprint training protocols.

Detailed description: Speed is one of the most important physical capacities for many sports, especially those that include speed and power as a major element, and plays a major role on performance. Thus, running speed improvement consists one of the most basic aims of a sprinter's and a power athlete's training program. One of the most commonly used strategies to improve the initial acceleration phase, is resisted sprint training. Evidence suggests that resisted sprint training is more effective in improving acceleration compared to sprint training without additional load. Sprinting is performed through the stretch-shortening cycle, where the pre-activated muscle is first stretched (eccentric action) and then followed by the shortening (concentric) action. Thus, sprint training highly includes the component of eccentric contraction. However, eccentric muscle action, especially when unaccustomed, can lead to exercise-induced muscle damage (EIMD). Although concentric and isometric exercise may also lead to muscle injury, the amount of damage after eccentric muscle contractions is greater. EIMD, amongst others, is accompanied by increased levels of creatine kinase (CK) into the circulation, increased delayed onset of muscle soreness (DOMS), reduction of force production, reduction of agility and speed. Nevertheless, despite the fact that sprint training comprises eccentric muscle actions and consequently can lead to muscle injury and muscle performance reduction during the following days, the recovery kinetics after acute sprint training have not been adequately studied. However, such information is critical for both coaches and athletes to effectively design the training microcycles and incorporate the training components, as well as to reduce injury risk.

The aim of the present study is to examine the recovery kinetics of EIMD indices, muscle performance and neuromuscular fatigue, after different sprint training protocols.

According to a preliminary power analysis (a probability error of 0.05, and a statistical power of 80%), a sample size of 8 - 10 subjects per group was considered appropriate in order to detect statistically meaningful changes between groups.

The study will be performed in a randomized, cross over, repeated measures design. During the first 1st and 2nd visit, all participants will sign an informed consent form after they will be informed about all the benefits and risks of the study and they will fill in and sign a medical history questionnaire. Fasting blood samples will be collected in order to estimate muscle damage concentration markers. Participants will be instructed by a dietitian how to record a 7-days diet recalls to ensure that they do not consume to greater extent nutrients that may affect EIMD and fatigue (e.g. antioxidants, amino acids, etc.) and to ensure that the energy intake during the trials will be the same. Assessment of body mass and body height, body composition, and aerobic capacity (VO2max), will be performed. Running speed of 10 m, 20 m and 30 m sprint will be measured on a track and field stadium. Squat jump and countermovement jump will be performed on a force platform to assess jump height, ground reaction force, peak and mean power, vertical stiffness and peak rate of force development; at the same time, peak and mean normalized EMG during the concentric phase of the squat jump, and during eccentric and concentric phases of the counter movement jump, for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles will be assessed. The peak concentric, eccentric and isometric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60°/sec. Maximal voluntary isometric contraction (MVIC) of the knee extensors at 65o in both limbs, as well as the fatigue rate during MVIC through the percent drop of peak torque between the first and the last three seconds of a 10-sec MVIC.

During the 3rd visit, participants will be randomly assigned into, and perform one of the four different conditions of the study design: a) unresisted sprint training, b) resisted sprint training with a load of 10% of body weight (BW), c) resisted sprint training with a load of 20% of BW d) control condition. Prior to each experimental protocol, assessment of DOMS in the knee flexors (KF) and extensors (KE) of both limbs, as well as blood lactate assessment will be performed. Additionally, DOMS of KF and KE, running speed at 10 m, 20 m and 30 m sprint, peak concentric, eccentric and isometric isokinetic torque, squat and countermovement jump height, as well as ground reaction force, peak and mean power, vertical stiffness and peak rate of force development during squat and countermovement jump, alongside with peak and mean normalized electromyography (EMG) during the concentric phase of the squat jump, and during eccentric and concentric phases of the counter movement jump, for the vastus lateralis, biceps femoris, gastrocnemius, and tibialis anterior muscles will be assessed immediately after, 24h, 48h and 72h after the end of the trial. MVIC of the knee extensors of both limbs, as well as the fatigue rate during MVIC will also be assessed at 1h, 2h and 3h, as well as 24h, 48h, and 72h after the end of the trial. Blood lactate will also be assessed at 4 min, while creatine kinase at 24h, 48h, and 72h after the end of the trial. The exact above procedures will be repeated by the participants during the remaining three experimental trials (7th - 10th, 11th - 13th, and 14th - 16th visits).

Eligibility criteria: Inclusion Criteria:

* Srinters or athletes that comprise sprint training in their training programs
* Absense of musculoskeletal injuries (≥ 6 months)
* Abstence from use of ergogenic supplements or other drugs (≥ 1 month)
* Abstence from participation at exercise with eccentric component (≥ 3 days)
* Abstence from alcohol and energy drings consumption before each experimental trial

Exclusion Criteria:

* Musculoskeletal injuries (≤ 6 months)
* Use of ergogenic supplements or other drugs (≤ 1 month)
* Participation at exercise with eccentric component (≤ 3 days)
* Alcohol and energy drings consumption before the experimental trials

Primary outcomes:
measure: Changes in Creatine kinase
timeFrame: Baseline (pre), post-, 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in DOMS
timeFrame: Baseline (pre), post-, 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in blood lactate
timeFrame: Baseline (pre), 4 minutes post-trial
measure: Changes in 10m sprint time
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in 20m sprint time
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in 30m sprint time
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in squat jump height
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in ground reaction force (GRF) during squat jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak power during squat jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in mean power during squat jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in vertical stiffness during squat jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak rate of force development (RFD) during squat jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak normalized EMG during squat jump test
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in mean normalized EMG during squat jump test.
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in countermovement jump height
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in ground reaction force (GRF) during countermovement jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak power during countermovement jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in mean power during countermovement jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in vertical stiffness during countermovement jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak rate of force development (RFD) during countermovement jump
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak normalized EMG during countermovement jump test
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in mean normalized EMG during countermovement jump test
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak concentric torque
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak eccentric torque
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in peak isometric torque
timeFrame: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in maximal voluntary isometric contraction (MVIC)
timeFrame: Baseline (pre), 1 hour post-, 2 hours post-, 3 hours post-, 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Changes in fatigue rate of maximal voluntary isometric contraction (MVIC)
timeFrame: Baseline (pre), 1 hour post-, 2 hours post-, 3 hours post-, 24 hours post-, 48 hours post-, 72 hours post-trial
measure: Change in field activity during the sprint training protocols
timeFrame: Throughout the sprint training protocols
measure: Change in heart rate during the sprint training protocols
timeFrame: Throughout the sprint training protocols
Secondary outcomes:
measure: Body weight
timeFrame: Baseline
measure: Body height
timeFrame: Baseline
measure: Body mass index (BMI)
timeFrame: Baseline
measure: Maximal oxygen consumption (VO2max)
timeFrame: Baseline
measure: Body fat
timeFrame: Baseline
measure: Lean body mass
timeFrame: Baseline
measure: Dietary intake
timeFrame: Baseline
Other outcomes:
Locations:
city: Trikala
country: Greece
facility: Department of Physical Education and Sport Science
state: Thessaly
Study officials:
affiliation: Department of Physical Education and Sport Science, University of Thessaly
name: Chariklia K Deli, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Zafeiridis A, Saraslanidis P, Manou V, Ioakimidis P, Dipla K, Kellis S. The effects of resisted sled-pulling sprint training on acceleration and maximum speed performance. J Sports Med Phys Fitness. 2005 Sep;45(3):284-90.
citation: Bachero-Mena B, Gonzalez-Badillo JJ. Effects of resisted sprint training on acceleration with three different loads accounting for 5, 12.5, and 20% of body mass. J Strength Cond Res. 2014 Oct;28(10):2954-60. doi: 10.1519/JSC.0000000000000492.
citation: Baird MF, Graham SM, Baker JS, Bickerstaff GF. Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery. J Nutr Metab. 2012;2012:960363. doi: 10.1155/2012/960363. Epub 2012 Jan 11.
citation: Deli CK, Fatouros IG, Paschalis V, Georgakouli K, Zalavras A, Avloniti A, Koutedakis Y, Jamurtas AZ. A Comparison of Exercise-Induced Muscle Damage Following Maximal Eccentric Contractions in Men and Boys. Pediatr Exerc Sci. 2017 Aug;29(3):316-325. doi: 10.1123/pes.2016-0185. Epub 2017 Feb 6.
citation: Petrakos G, Morin JB, Egan B. Resisted Sled Sprint Training to Improve Sprint Performance: A Systematic Review. Sports Med. 2016 Mar;46(3):381-400. doi: 10.1007/s40279-015-0422-8.